Investor Relations
-
Message from the Chairman and CEO
We are working to meet the expectations of our shareholders and investors by enhancing corporate value.
-
Business Results For the First Three Months of the Fiscal Year Ending March 31, 2020
IR Information
-
- Updated: Sysmex Report 2019
-
- Development of a Fully Automated Measurement Method for Soluble Immune Checkpoint Molecules (sPD-1, sPD-L1 and sCTLA-4)
-
- Notice of Decisions on the Details of Stock Option Issuance (PDF：170KB)
-
- Sysmex Launches Caresphere™ QM, an Operational Support System for Testing Quality Management
-Realizing the Operation of High-Quality Clinical Laboratories through our New Caresphere™ Solution- -
- Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year
